Heterogeneity of toxicant response: Sources of human variability

被引:41
作者
Aldridge, JE
Gibbons, JA
Flaherty, MM
Kreider, ML
Romano, JA
Levin, ED
机构
[1] Duke Univ, Med Ctr, Dept Psychiat, Durham, NC 27710 USA
[2] Duke Univ, Med Ctr, Integrated Toxicol Program, Durham, NC 27710 USA
[3] Duke Univ, Med Ctr, Dept Pharmacol, Durham, NC 27710 USA
[4] Duke Univ, Med Ctr, Dept Canc Biol, Durham, NC 27710 USA
[5] Duke Univ, Med Ctr, Biol Chem Program, Durham, NC 27710 USA
[6] Duke Univ, Dept Chem, Durham, NC 27708 USA
[7] Duke Univ, Marine Lab, Nicholas Sch Environm, Beaufort, NC 28516 USA
关键词
D O I
10.1093/toxsci/kfg204
中图分类号
R99 [毒物学(毒理学)];
学科分类号
100405 ;
摘要
While risk assessment models attempt to predict human risk to toxicant exposure, in many cases these models cannot account for the wide variety of human responses. This review addresses several primary sources of heterogeneity that may affect individual responses to drug or toxicant exposure. Consideration was given to genetic polymorphisms, age-related factors during development and senescence, gender differences associated with hormonal function, and preexisting diseases influenced by toxicant exposure. These selected examples demonstrate the need for additional steps in risk assessment that are needed to more accurately predict human responses to toxicants and drugs.
引用
收藏
页码:3 / 20
页数:18
相关论文
共 130 条
[51]   Products of aqueous chlorination of bisphenol A and their estrogenic activity [J].
Hu, JY ;
Aizawa, T ;
Ookubo, S .
ENVIRONMENTAL SCIENCE & TECHNOLOGY, 2002, 36 (09) :1980-1987
[52]  
Hu Y, 1997, MOL PHARMACOL, V51, P370
[53]  
HUFF RA, 1995, NEUROTOXICOLOGY, V16, P281
[54]  
HUFF RA, 1994, J PHARMACOL EXP THER, V269, P329
[55]  
Ingelman-Sundberg M, 2001, TOXICOL LETT, V120, P259, DOI 10.1016/S0378-4274(01)00278-8
[56]   Polymorphic human cytochrome P450 enzymes: an opportunity for individualized drug treatment [J].
Ingelman-Sundberg, M ;
Oscarson, M ;
McLellan, RA .
TRENDS IN PHARMACOLOGICAL SCIENCES, 1999, 20 (08) :342-349
[57]   Genetic susceptibility to adverse effects of drugs and environmental toxicants - The role of the CYP family of enzymes [J].
Ingelman-Sundberg, M .
MUTATION RESEARCH-FUNDAMENTAL AND MOLECULAR MECHANISMS OF MUTAGENESIS, 2001, 482 (1-2) :11-19
[58]   Genetic polymorphisms in heterocyclic amine metabolism and risk of colorectal adenomas [J].
Ishibe, N ;
Sinha, R ;
Hein, DW ;
Kulldorff, M ;
Strickland, P ;
Fretland, AJ ;
Chow, WH ;
Kadlubar, FF ;
Lang, NP ;
Rothman, N .
PHARMACOGENETICS, 2002, 12 (02) :145-150
[59]   Maintenance therapy with zuclopenthixol decanoate:: associations between plasma concentrations, neurological side effects and CYP2D6 genotype [J].
Jaanson, P ;
Marandi, T ;
Kiivet, RA ;
Vasar, V ;
Vään, S ;
Svensson, JO ;
Dahl, ML .
PSYCHOPHARMACOLOGY, 2002, 162 (01) :67-73
[60]  
JARABEK AM, 1995, J HUM ECOL RISK ASSE, V15, P641